Skip to main
WELL

Welltower (WELL) Stock Forecast & Price Target

Welltower (WELL) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 25%
Buy 56%
Hold 19%
Sell 0%
Strong Sell 0%

Bulls say

Welltower is a well-established healthcare REIT with a strong portfolio of diversified healthcare properties, especially in the senior housing sector. The company's data analytic capabilities and strong operator relationships have enabled it to outperform the industry, and the implementation of the Welltower Business System is expected to further enhance its performance. The company's strong investment pipeline, expected growth in its seniors housing business, and strategic initiatives should support elevated FFO/AFFO growth for the foreseeable future. Risks to the outlook include economic and regulatory factors, as well as the current valuation of the stock.

Bears say

Welltower is facing potential disruption to their operations as they continue to roll out their WBS platform and adapt to new procedures, resulting in initial dilution and potential disruptions to staff. The company's growth prospects are largely dependent on continued success in deploying capital and achieving healthy occupancy gains, which may be impacted by factors such as employment growth and potential government funding cuts. The company also faces risks related to stock valuation and potential problems in underwriting. Overall, there are too many potential risks and uncertainties surrounding Welltower's growth prospects, leading to a negative outlook.

Welltower (WELL) has been analyzed by 16 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 56% recommend Buy, 19% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Welltower and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Welltower (WELL) Forecast

Analysts have given Welltower (WELL) a Buy based on their latest research and market trends.

According to 16 analysts, Welltower (WELL) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $247.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $247.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Welltower (WELL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.